Home › Funds › ACUTA CAPITAL PARTNERS, LLC › STOK
ACUTA CAPITAL PARTNERS, LLC position in STOK
STOKE THERAPEUTICS INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 5,771 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$150K, representing 0.12% of its reported portfolio and ranking #34 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's STOK position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in STOK in Q3 2026 at 5,771 shares (US$150K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 5.77K | $150.05K | New |
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$146.2M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $146.21M · Q3 2026
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M sh · $103.83M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- Siren, L.L.C. 2.00M sh · $51.88M · Q3 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- EcoR1 Capital, LLC 835.00K sh · $21.71M · Q3 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held STOK?
ACUTA CAPITAL PARTNERS, LLC has disclosed STOK holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in STOK?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 5.77K shares of STOK (STOKE THERAPEUTICS INC), valued at $150.05K, representing 0.12% of its reported portfolio and ranking #34.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling STOK?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in STOK.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.